LinkedIn Outreach That Opens Biotech Doors.
Leadriver runs LinkedIn outreach campaigns that reach VP Business Development, Heads of Commercial, Chief Scientific Officers, and Licensing Directors at your target B2B biotech, life sciences, and pharma technology companies: with personalised connection requests, message sequences, and follow-up that earns real conversations.
34%
22%
Of connections convert to conversations
7
Days to first LinkedIn reply
18+
Industries served
Why Biotech Outbound Fails for Most Teams
Life sciences buyers are highly selective and sceptical of outreach from vendors who do not understand clinical development timelines, regulatory pathways, or scientific rigour.
We write sequences that reference clinical development context, regulatory timelines, and scientific credibility: the language that opens doors in life sciences.
Life sciences purchasing often follows clinical or regulatory milestones. Without ongoing outbound activity aligned to those timelines, you miss the windows when buyers have budget and mandate to act.
We identify the right buyer at each company based on their development stage and your product's position in the value chain.
Biotech sales cycles are among the longest in B2B. Building internal outbound capability for this audience requires domain expertise that is rare and expensive to hire.
Every meeting handoff includes the prospect's pipeline context and development stage so your team leads with a precisely relevant case.
The right buyer in a life sciences organisation depends on whether the product touches R&D, clinical operations, regulatory affairs, or commercial launch. Each function has different priorities and different vocabulary.
We have run over 2,000 outbound campaigns across 18 industries and generated more than 85,000 interested leads. Our team understands the Biotech market and writes accordingly.
How We Run LinkedIn Outreach in the Biotech Market
Profile Optimisation and Sender Setup
Before any outreach begins, we review and strengthen the sender LinkedIn profile: headline, about section, and featured content. A credible profile is the foundation of LinkedIn outreach. We set up the technical infrastructure for safe, compliant sending.
Biotech-Specific Connection and Message Sequences
We write connection requests and follow-up message sequences tailored to biotech buyers context and timed around clinical trial phase transitions, regulatory submissions, commercial launch preparation, and partnership or licensing rounds. Every message is personalised to the recipient's role, company, and industry reality.
Connection Management and Conversation Handling
We manage the inbox, respond to queries, handle objections, and qualify interested prospects before they reach your calendar. You only engage once a conversation is warm.
Weekly Reporting and Sequence Optimisation
Weekly reports cover connection rates, reply rates, and meeting conversion by persona and sequence variant. We optimise based on what the data tells us each week.
What LinkedIn Outreach Delivers in the Biotech Market
in 90 days
For a clinical data management platform targeting VP Clinical Operations and Heads of Data Management at Phase II and III biotech companies across Europe.
Clinical Data / Biotech
in two quarters
A regulatory submission platform targeting Heads of Regulatory Affairs at mid-size specialty pharma companies generated two enterprise contracts from a 180-day programme.
Regulatory Tech / Biotech
to first meeting
A clinical trial management platform booked its first qualified VP Clinical Operations conversation within 16 days of launching outbound.
CTMS / Biotech
Questions About LinkedIn Outreach for Biotech
Open More Biotech Doors on LinkedIn.
Book a discovery call and we will show you the LinkedIn market size for your target Biotech buyers and what a realistic outreach programme looks like for your offer.
Book Your Discovery Call